The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia.
Ontology highlight
ABSTRACT: OBJECTIVE: To determine the costs and catastrophic costs incurred by drug-susceptible (DS) pulmonary TB patients in The Gambia.METHODS: This observational study collected cost and socio-economic data using a micro-costing approach from the household perspective from 244 adult DS-TB patients with pulmonary TB receiving treatment through the national treatment programme in The Gambia. We used data collected between 2017 and 2020 using an adapted version of the WHO generic patient cost survey instrument to estimate costs and the proportion of patients experiencing catastrophic costs (≥20% of household income).RESULTS: The mean total cost of the TB episode was $104.11 (2018 USD). Direct costs were highest before treatment ($22.93). Indirect costs accounted for over 50% of
SUBMITTER: Devoid I
PROVIDER: S-EPMC9728947 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA